SUMMARY Because somatostatin, a neuroregulatory peptide, is found in abundance in the atria and atrioventricular node, its electrophysiological and antiarrhythmic properties were compared with those of verapamil in ten patients with paroxysmal atrioventricular tachycardia. During sinus rhythm, intravenous somatostatin slowed the heart rate whereas verapamil increased it. Though both agents prolonged atrioventricular conduction time and refractoriness, verapamil was more potent. They were equally effective at terminating reentry atrioventricular tachycardia, restoring sinus rhythm in six of seven patients. Whereas verapamil consistently blocked conduction in the atrioventricular node, somatostatin usually induced ventricular extrasystoles at the time of conversion. Somatostatin may have physiological importance in the neurohumoral control of cardiac impulse formation and conduction.
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Somatostatin and related peptides have been identified in many tissues from a wide range of species including man.' 2 Within the central nervous system, somatostatin functions as a neurohumoral agent and participates in neurotransmission.3 In other organs it inhibits endocrine and exocrine secretions and depresses absorption from the small bowel as well as slowing splanchnic blood flow.4
In addition, somatostatin is present in the normal heart' and has various effects on the cardiovascular system. These include bradycardia in Accepted for publication 13 May 1986 tration of the perfusing medium"°; this has raised the question whether somatostatin may act as a calcium antagonist.
To explore the electrophysiological role of somatostatin, and also to assess its possible therapeutic usefulness, we have compared its effects with those of verapamil in a group of patients undergoing investigation of paroxysmal supraventricular tachycardia. We determined the effects of both drugs on standard measurements of intracardiac conduction velocity and refractoriness during sinus rhythm, and also examined their antiarrhythmic properties in those patients in whom reentry atrioventricular tachycardia could reproducibly be induced.
Patients and methods
Ten patients underwent routine intracardiac electrophysiological investigation of paroxysmal supraventricular tachycardia. After premedication with oral diazepam, four multipolar recording electrode wires were introduced percutaneously via the right femoral and left subclavian veins to permit recording and stimulation from high right atrium, coronary sinus, bundle of His, and right ventricular Electrophysiological actions of somatostatin pg/min. This failed to prevent nausea in four subjects or abdominal discomfort in one. The infusion, however, produced a > 100 fold increase in the plasma somatostatin concentration, and the progressive reduction in the circulating concentrations of motilin and pancreatic polypeptide indicated that a therapeutically effective concentration of somatostatin had been achieved. 27 In conjunction with the observation that somatostatin is present in cardiac tissue,5 the demonstration that this peptide possesses electrophysiological properties suggests that it may have a functional role within the cardiovascular system. The effects of exogenous somatostatin on the sinus and atrioventricular nodes resemble those of vagal stimulation. The localisation of somatostatin in postganglionic intracardiac neurones in the toad 3 and the efficacy of atropine in antagonising its chronotropic and dromotropic effects in man8 provide further evidence that somatostatin may participate in the mediation of cardiac parasympathetic tone. Somatostatin is known to function as a neuroregulator and cotransmitter at other sites in the autonomic and central nervous systems.28 29 Fur-240 group.bmj.com on October 14, 2017 -Published by http://heart.bmj.com/ Downloaded from ther studies are required to establish the role of this peptide at cardiac neuroeffector junctions. Immunocytochemical examination of human sinus and atrioventricular nodal tissue, detailed assessment of the effects of somatostatin on isolated heart preparations, and clinical tests with coadministration of autonomic agonists and antagonists are in progress.
